Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest pharmaceutical industry Stories

2014-03-19 08:22:20

ALDERLEY EDGE, England, March 19, 2014 /PRNewswire/ -- Gentronix Limited, the leading specialist genotoxicity company, has announced its strategic intention to offer regulatory genotox assays, and is currently working towards 'Good Laboratory Practice' (GLP) compliance. GLP is a quality system of management controls for research laboratories to ensure the quality and reliability of test data from non-clinical safety studies. Specifically, these are studies to examine...

2014-03-18 23:01:55

The 26th annual EuroMeeting, coming to Austria’s capital from 25-27 March, will feature more than 100 sessions in 16 parallel themes and the chance to hear from 300+ expert speakers, including representatives from the European Medicines Agency (EMA), the European Commission and regulatory agencies from around the world. BASEL, SWITZERLAND (PRWEB) March 18, 2014 In less than one week’s time more than 2,500 professionals from around the world will gather in Vienna at DIA’s largest...

2014-03-18 12:27:59

ROCKVILLE, Md., March 18, 2014 /PRNewswire/ -- MMG, a full-service global health communications company specializing in clinical-trial patient recruitment and retention, today announced an exclusive strategic partnership with online healthcare communications company MedRespond to introduce a new technological advancement in clinical-trial patient education, Custom Conversations. Custom Conversations harnesses the engaging power of video, the specificity of natural language query...

2014-03-18 08:33:42

New Board Will Advise Mytrus On Developing Innovative New Products Essential For Improving Research and the Patient Experience in Clinical Trials BURLINGTON, Mass., March 18, 2014 /PRNewswire/ --inVentiv Health, a life science knowledge and services company for the new healthcare environment, announced today the creation of a new Innovation Advisory Board comprised of leading industry experts who will help shape the future of clinical products and services offered by Mytrus, a...

2014-03-18 08:33:23

CAMBRIDGE, England and BOSTON, March 18, 2014 /PRNewswire/ Linguamatics' sales showed strong growth and exceeded ten million dollars in 2013, it was announced today - outperforming the company's targeted growth and expected sales figures. The increased sales came from a boost in new customers and increased software licenses to existing customers in the pharmaceutical and healthcare sectors. This included 130 per cent growth in healthcare sales plus increased sales in professional services....

2014-03-18 08:26:31

LONDON, March 18, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:Liver Transplantation Global Clinical Trials Review, H2, 2013 Liver Transplantation Global Clinical Trials Review, H2, 2013SummaryGlobalData's clinical trial report, "Liver Transplantation Global Clinical Trials Review, H2, 2013" provides data on the Liver Transplantation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on...

2014-03-18 04:21:58

ZURICH, March 18, 2014 /PRNewswire/ -- Takeda Pharmaceuticals International GmbH ("Takeda") today announced that Giles Platford has been appointed Head of Commercial Operations, Emerging Markets, reporting to Christophe Weber, Chief Operating Officer of Takeda Pharmaceutical Company Limited as of April 1, 2014. In this role he will be responsible for leading the continued expansion of Takeda's commercial activities in this region, which comprises Russia-CIS, Latin...

2014-03-17 08:29:38

View the White Paper at: www.expectad.com/wp.pdf CLIFTON, N.J., March 17, 2014 /PRNewswire-iReach/ -- In an ongoing effort to promote the usage of FDA-approved drugs, Medicast, Inc., a medicaleducation organization, has released a White Paper -- The Hazards of Unapproved Drugs and Importance of Utilizing Approved Drugs. (Photo: http://photos.prnewswire.com/prnh/20140317/MN84069) The White Paper was developed by a leading hospital pharmacist - Cindy Ippoliti, Pharm.D., NYP/Weill...

2014-03-16 23:02:36

Pharmaceutical leaders implement Model N to improve margins and mitigate risk, as surveys highlight growing urgency in responding to global pricing pressures. Redwood Shores, CA (PRWEB) March 16, 2014 Four global pharmaceutical giants have gone live with Model N Global Price Management (GPM) in the past three months, as they look to optimize margin performance and reduce risk. This reflects increased momentum in the pharmaceutical industry to adopt revenue management solutions in the face...

2014-03-16 23:00:43

Purdue University and Houston Methodist Research Institute plan to collaborate on research and educational initiatives, including clinical trials of drugs developed at Purdue. West Lafayette, IN (PRWEB) March 16, 2014 Purdue University and Houston Methodist Research Institute plan to collaborate on research and educational initiatives, including clinical trials of drugs developed at Purdue. The partnership helps to advance the Purdue Moves drug discovery initiative to translate basic...